muhc

Hydroxychloroquine shortages: when the enthusiasm for a potential cure affects patients

Published: 25Jun2020

Amid initial public and scientific optimism for hydroxychloroquine (HCQ) as a potential treatment for COVID-19, health care professionals raised concerns about shortages of this inexpensive drug,...

Male fertility after chemotherapy: new questions raised

Published: 22Jan2020

A pilot study conducted by INRS and McGill researchers highlights the effect of chemotherapy on male fertility before and after puberty....

Potential gender bias against female researchers in peer review of research grants

Published: 23Apr2018

Female health researchers who applied for grants from Canada's major health research funder were funded less often than male counterparts because of potential bias, and characteristics of peer...

Tackling adherence to treatment on several fronts

Published: 27Mar2018

Learning to become self-sufficient and responsible is part of life’s journey through the teen and young adult years. Mistakes are often made, and lessons are learned. However, for young kidney...

Pushing screening of ovarian and endometrial cancers one step further

Published: 21Mar2018

A team from the Research Institute of McGill University Health Centre (RI-MUHC) in Montreal has joined forces with researchers at Johns Hopkins to bring screening and early detection of ovarian and...

Meet RIPK3: Good Cop, Bad Cop, all in one

Published: 14Feb2018

Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have...

Epigenetic alteration of a vitamin B12 processing gene shines new light on our understanding of rare diseases

Published: 30Jan2018

Rare hereditary recessive diseases were thought to be expressed in offspring only when both parents carry a mutation in the causal gene, but a new study is changing this paradigm. An international...

Pages

Back to top